Company Filing History:
Years Active: 2008-2011
Title: The Innovations of Benxian Liu
Introduction
Benxian Liu is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for treating obesity and related diseases. With a total of 14 patents to his name, Liu's work has the potential to impact the health and wellness of many individuals.
Latest Patents
Liu's latest patents include groundbreaking inventions such as "Methods for treating obesity using fibroblast growth factor-like polypeptides." This invention provides methods for reducing body weight in mammals using Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. Another notable patent is "Identifying modulators of fibroblast growth factor-like polypeptides," which introduces novel FGF-like polypeptides and nucleic acid molecules. This invention also encompasses vectors, host cells, antibodies, and methods for producing FGF-like polypeptides, along with methods for diagnosing and treating diseases associated with these polypeptides.
Career Highlights
Benxian Liu is currently associated with Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to further his research and development efforts in the field of fibroblast growth factors.
Collaborations
Liu has collaborated with notable colleagues such as Arlen Read Thomason and Dimitry Michael Danilenko. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Benxian Liu's contributions to biotechnology through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to pave the way for new treatments and therapies that can benefit many individuals.